NI
JNP

Numeric Investors’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Numeric Investors’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-79,300
Closed -$577K – 936
2013
Q3 		$577K Buy
+79,300
New +$534K 0.01% 556

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Numeric Investors's JNP Position: Q4 2013 in Review

Numeric Investors sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2013, closing a stake of 79,300 shares — an estimated $577K sold.

Numeric Investors first reported a position in JNP in Q3 2013 and held it in 1 quarter. The position peaked at $577K in Q3 2013. 31 funds tracked by Wall St. Rank hold JNP as of Q4 2013.

  • Numeric Investors reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Numeric Investors sold 79,300 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2013, an estimated $577K.
  • Numeric Investors first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • Numeric Investors's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $577K in Q3 2013.
  • 31 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2013.

Based on Numeric Investors's 13F filing for Q4 2013, filed 5 Feb 2014.